Trials / Completed
CompletedNCT01562002
Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome
Advanced Therapy for Ocular Surface Reconstruction. Allogenic Limbus Epithelial Stem-cell Transplant vs Bone Marrow Mesenchymal Stem-cell Transplant in Limbus Insufficiency Syndrome. Double-masked Randomized Trial
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine whether allogenic bone marrow stem cell transplant is safe and effective in the treatment of limbus insufficiency syndrome versus allogenic limbus stem cell transplant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Stem Cell with Amniotic Membrane Transplant | Single stem cell expansion in amniotic membrane transplant |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2012-03-23
- Last updated
- 2015-01-08
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01562002. Inclusion in this directory is not an endorsement.